Gastrointestinal Stromal Tumors (GIST): an Overview

被引:0
作者
Sanjeev K. Gupta
Nisha Rateria
机构
[1] Banaras Hindu University,Department of General Surgery, Institute of Medical Sciences
来源
Indian Journal of Surgery | 2021年 / 83卷
关键词
gastrointestinal stromal tumors; imatinib; mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Gastrointestinal stromal tumors are rare mesenchymal tumors of the alimentary tract with varied clinical presentation ranging from small asymptomatic tumors detected incidentally to large palpable abdominal masses which may present with gastrointestinal bleeding, perforation, or obstruction. CT abdomen is the imaging modality of choice. Treatment depends upon the size, location and risk stratification. Complete surgical excision is the treatment of choice for resectable tumours. The discovery of c-kit mutations and tyrosine-kinase inhibitors has revolutionized the treatment of locally advanced, metastatic and recurrent tumors.
引用
收藏
页码:647 / 653
页数:6
相关论文
共 26 条
[1]  
Szucs Z(2017)Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications Future Oncol 13 93-107
[2]  
Thway K(2016)Diagnostic and treatment strategy for small gastrointestinal stromal tumors Cancer 122 3110-3118
[3]  
Fisher C(2006)Gastrointestinal stromal tumors: pathology and prognosis at different sites SeminDiagnPathol 23 70-83
[4]  
Bulusu R(2006)Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis Arch Pathol Lab Med 130 1466-1478
[5]  
Constantinidou A(2017)How best to manage gastrointestinal stromal tumor World J Clin Oncol 8 135-144
[6]  
Benson C(2008)Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinibmesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by Cancer and Leukemia Group B and Southwest Oncology Group J Clin Oncol 26 5360-5367
[7]  
Graaf WTA(2007)Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance Ann Surg Oncol 14 1247-1248
[8]  
Jones RL(2014)Analysis of prognostic factors impacting oncologicoutcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromaltumors Ann Surg Oncol 21 2499-2505
[9]  
Nishida T(2016)Contemporary management of metastatic gastrointestinal stromal tumors: systemic and locoregional approaches OncolTher 4 1-16
[10]  
Goto O(undefined)undefined undefined undefined undefined-undefined